Recipient of a “Making A Difference Award” Earned "Exceeds Expectations" ratingRecipient of BRAVO Awards for work to increase cross-functional and cross-therapeutic area collaborations MSL Study LeadEarly Development Product Lead

-Develop and maintain a relationship with key opinion leaders in oncology through scientific exchange-Facilitate clinical research collaborations -Provide clinical and/or pipeline presentations and information in response to unsolicited requests in academic and community healthcare settings-Attend and provide scientific support at congresses-Therapeutic area expertise in hematology and oncology

Classification of BRCA1 variants for the Breast Cancer Information Core (BIC)

• Led the formation of Avalere Patient Centeredness Task Force • Moderated a webinar on Patient Perspective in Drug Development: Whose Opinion Counts Most?• Invited speaker at the Health Policy and Clinical Practice for Patients with Multiple Chronic Conditions, March 2015, - Presentation on Patient Perspective in Drug Development (http://ns2.interchangesserver.com/2015PolicyFaculty.htm)

Successfully wrote and obtained a contract with the Florida Department of Health-Responsible for searching, evaluating and developing training curriculum for community health workers

This position examined community-based approaches currently used in informed medical decision making initiatives. The project was a joint initiative between the H. Lee Moffitt Cancer Center and University of South Florida. • Conducted systematic literature review of the role of Community health workers (CHWs) in changing knowledge, attitudes and behavior about cancer in under-served populations• Developed training module for CHWs through the Comparative Effectiveness Research for Eliminating Disparities (CERED) core • Reviewer of clinical trial protocols for physicians at USF/Tampa General Hospital and other health care facilities in the area

Performed business process analysis and recommend areas of improvement in quality assurance and control. Wrote a Quality Assurance Program Plan for the Health and Life Sciences division.Worked on improving existing processes and SOPs utilizing system/process audits as a member of the QA teamAssumed the role of a tester for a major software releaseMaintained support inbox/phone line for over 5,000 clients globally Provided quality oversight of BioEd documentation and services, Participated in BioEd strategy meetings, Participated in BioEd on-line (self-paced) and live course development.Continued education:Role of RA Professional, 2010Six Sigma: Total Quality Applications, 2009 Medical Terminology: A Word Association Approach, 2009 Six Sigma: Total Quality Fundamentals, 2009 Clinical Trial Quality Assurance - Defining the Gold Standard 2008

While on assignment at the National Institutes of Health, I used my expertise in Molecular Biology as a member of the Educational Outreach Team at the National Center for Biotechnology Information (NCBI). My work encompassed teaching and development of the primary scientific outreach and training programs as well as daily communication with the users of the NCBI´s databases.(IMC, Inc. contractor)Continued Education:Project Management Overview, 2008

In this position, I was responsible for planning and conducting experiments for 3 separate projects. One specific project dealt with the identification and development of new biomarkers for early detection of breast and ovarian cancers and identification and development of new biomarkers to predict for adverse reaction to radiation therapy. In addition to preparing manuscripts and fellowship applications and assisting in preparation of grant applications, I presented my work at scientific conferences. In addition to my research, I had an active role in training of new graduate and undergraduate students rotating through the laboratory. My leadership experience includes serving as the Chair of the Moffitt Postdoctoral Association, where I provided career guidance to postdoctoral fellows and graduate students through organization of career seminars. Through the collaboration with the senior administration, I established travel awards for postdoctoral fellows.

In this position, I conducted biophysical studies on G-rich oligonucleotides as novel anti-cancer agents and identified novel targets for G-rich oligonucleotides. My work contributed to the identification of AS1411, one of the GROs that was studied in Phase II clinical trials (www.antisoma.com). My abstract was selected for a talk at a Molecular Targets for Cancer Therapy 2nd Biennial Meeting, St. Petersburg, FL 2002. Experience: Drug DevelopmentProject designMentoringCommunication